These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 15007380)
1. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Vultur A; Cao J; Arulanandam R; Turkson J; Jove R; Greer P; Craig A; Elliott B; Raptis L Oncogene; 2004 Apr; 23(15):2600-16. PubMed ID: 15007380 [TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660 [TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415 [TBL] [Abstract][Full Text] [Related]
4. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism. Lo RK; Cheung H; Wong YH J Biol Chem; 2003 Dec; 278(52):52154-65. PubMed ID: 14551213 [TBL] [Abstract][Full Text] [Related]
5. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Badache A; Hynes NE Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675 [TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720 [TBL] [Abstract][Full Text] [Related]
9. Fer is a downstream effector of insulin and mediates the activation of signal transducer and activator of transcription 3 in myogenic cells. Taler M; Shpungin S; Salem Y; Malovani H; Pasder O; Nir U Mol Endocrinol; 2003 Aug; 17(8):1580-92. PubMed ID: 12738762 [TBL] [Abstract][Full Text] [Related]
10. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Song L; Turkson J; Karras JG; Jove R; Haura EB Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cells. Anagnostopoulou A; Vultur A; Arulanandam R; Cao J; Turkson J; Jove R; Kim JS; Glenn M; Hamilton AD; Raptis L Cancer Lett; 2006 Oct; 242(1):120-32. PubMed ID: 16377083 [TBL] [Abstract][Full Text] [Related]
12. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187 [TBL] [Abstract][Full Text] [Related]
13. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Gray MJ; Zhang J; Ellis LM; Semenza GL; Evans DB; Watowich SS; Gallick GE Oncogene; 2005 Apr; 24(19):3110-20. PubMed ID: 15735682 [TBL] [Abstract][Full Text] [Related]
15. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells. Laird AD; Li G; Moss KG; Blake RA; Broome MA; Cherrington JM; Mendel DB Mol Cancer Ther; 2003 May; 2(5):461-9. PubMed ID: 12748308 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Aznar S; Valerón PF; del Rincon SV; Pérez LF; Perona R; Lacal JC Mol Biol Cell; 2001 Oct; 12(10):3282-94. PubMed ID: 11598209 [TBL] [Abstract][Full Text] [Related]
17. Differential role of Janus family kinases (JAKs) in interferon-gamma-induced lung epithelial ICAM-1 expression: involving protein interactions between JAKs, phospholipase Cgamma, c-Src, and STAT1. Chang YJ; Holtzman MJ; Chen CC Mol Pharmacol; 2004 Mar; 65(3):589-98. PubMed ID: 14978237 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of potential Stat3-regulated genes in human breast cancer. Hsieh FC; Cheng G; Lin J Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048 [TBL] [Abstract][Full Text] [Related]
19. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor. Plaza Menacho I; Koster R; van der Sloot AM; Quax WJ; Osinga J; van der Sluis T; Hollema H; Burzynski GM; Gimm O; Buys CH; Eggen BJ; Hofstra RM Cancer Res; 2005 Mar; 65(5):1729-37. PubMed ID: 15753368 [TBL] [Abstract][Full Text] [Related]
20. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation. Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]